GTx's competitors

GTx's competitors include Epizyme, Rexahn Pharmaceuticals, PDL BioPharma and Bellicum Pharmaceuticals
Add company...
GTx
GTx, Inc is a pharmaceutical company and developer of drugs that utilize hormonal pathways.
Epizyme
Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.
Rexahn Pharmaceuticals
Rexahn Pharmaceuticals develops treatments for cancer, central nervous system disorders, and other unmet medical needs in the United States.
PDL BioPharma
PDL BioPharma, Inc. engages in intellectual property asset management, and patent portfolio and related assets investment activities.
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovering and developing first-in-class cellular immunotherapies for hematological cancers and solid tumors.
Founding Date
Founding Date
1997
Founding Date
2007
Founding Date
2001
Founding Date
1986
Founding Date
2004
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Memphis, US HQ
Locations
Cambridge, US HQ
Locations
Rockville, US HQ
Locations
Incline Village, US HQ
Locations
Houston, US HQ
Employees
Employees
26 10% decrease
Employees
112
Employees
20
Employees
11
Employees
110
Valuation ($)
Valuation ($)
249.1 m
Valuation ($)
1.1 b
Valuation ($)
50.7 m
Valuation ($)
376.2 m
Valuation ($)
219 m
Twitter followers
Twitter followers
N/A
Twitter followers
954
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
337

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$8m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
$244.3m (FY, 2016)
Revenue (est.)
N/A
Net income
Net income
($6.9m) (FY, 2016)
Net income
($110.2m) (FY, 2016)
Net income
($9.3m) (FY, 2016)
Net income
N/A
Net income
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles